InvestorsHub Logo
Followers 33
Posts 5290
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Friday, 12/17/2021 3:24:17 PM

Friday, December 17, 2021 3:24:17 PM

Post# of 426579
Footnotes from the Edding financials for vascepa sales see below. Keep in mind V is still is clinical trial 111. This is a footnote from financials and is as of 6/2021.
RMB is the Chinese Yuan 3.5mill converted to US dollars =$548,985.

(1) In December 2020, we entered into an exclusive distribution agreement with a distributor for pilot sales of Vascepa in
Hainan province according to the PRC laws and regulations regulating urgent clinical needs for imported drugs, and
therefore generated revenue of RMB3.5 million from sales of Vascepa in the six months ended June 30, 2021.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News